Effects of pantoprazole 20 mg in mild gastroesophageal reflux disease: Once-daily treatment in the acute phase, and comparison of on-demand versus continuous treatment in the long term

Current Therapeutic Research - Clinical and Experimental

Volumn 66, Issue 4, 2005, Pages 345-363

  Janssen, Werner ^a   Meier, Eberhard ^a   Gatz, Gudrun ^b   Pfaffenberger, Bernd ^b  

^a ALTANA Pharma AG ^*

^b ALTANA PHARMA AG   (Germany)

Author keywords

As needed; Continuous; Drug administration schedule; Follow up study; Gastroesophagealreflux drug therapy; Heartburn; Long term care; On demand; Pantoprazole; Treatment outcome

Indexed keywords

PANTOPRAZOLE;

ADULT; ARTICLE; BRONCHITIS; CALCULATION; CERVICOBRACHIAL NEURALGIA; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; ENDOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; HEARTBURN; HUMAN; KAPLAN MEIER METHOD; LONG TERM CARE; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SWALLOWING; TREATMENT FAILURE;

EID: 24944500837     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.curtheres.2005.08.012     Document Type: Article

References (29)

1. Dent J., Brun J., Fendrick A.M. Genval Workshop Group An evidencebased appraisal of reflux disease management-The Genval Workshop Report Gut. 44 Suppl 2 1999 S1 S16
2. Lind T., Havelund T., and Lundell L. On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis-a placebocontrolled randomized trial Aliment Pharmacol Ther. 13 1999 907 914
3. Talley N.J., Lauritsen K., and Tunturi-Hihnala H. Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: A controlled trial of 'on-demand' therapyfor 6 months Aliment Pharmacol Ther. 15 2001 347 354
4. Talley N.J., Venables T.L., and Green J.R. Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: A placebo-controlled trial of on-demand therapy for 6 months Eur J Gastroenterol Hepatol. 14 2002 857 863
5. Kao A.W., Sheu B.S., and Sheu M.J. On-demand therapy for Los Angeles Grade A and B reflux esophagitis: Esomeprazole versus omeprazole J Formos Med Assoc. 102 2003 607 612
6. Johnsson F., Mourn B., and Vilien M. On-demand treatment in patients with oesophagitis and reflux symptoms: Comparison of lansoprazole and omeprazole Scand J Gastroenterol. 37 2002 642 647
7. Tsai H.H., Chapman R., and Shepherd A. Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negativegastro-oesophageal reflux patients: The COMMAND study Aliment Pharmacol Ther. 20 2004 657 665
8. Abstract Cooper A.L., and Baxter G. Efficacy of lansoprazole on demand therapy in the treatment of non-erosive ref lux disease and functional ulcer-like dyspepsia Gut. 52 Suppl 6 2003 A137
9. Ponce J., Arguello L., and Bastida G. On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: Effectiveness, health-related quality of life, and patient satisfaction Dig Dis Sci. 49 2004 931 936
10. Bytzer P., Blum A., De Herdt D., Dubois D., and Trial Investigators Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive ref lux disease Aliment Pharmacol Ther. 20 2004 181 188
11. Galmiche J.P., Shi G., and Simon B. On-demand treatment of gastro-oesophageal ref lux symptoms: A comparison of ranitidine 75 mg with cimetidine 200 mg or placebo Aliment Pharmacol Ther. 12 1998 909 917
12. Wilhelmsen I., Hatlebakk J.G., Olafsson S., and Berstad A. On demand therapy of reflux oesophagitis - a prospective study of symptoms, patient satisfaction and quality of life Aliment Pharmacol Ther. 13 1999 1035 1040
13. Bytzer P., and Blum A.L. Personal view: Rationale and proposed algorithms for symptombased proton pump inhibitor therapy for gastro-oesophageal reflux disease Aliment Pharmacol Ther. 20 2004 389 398
14. Hungin A.P., Rubin G., and O'Flanagan H. Factors influencing compliance in long-term proton pump inhibitor therapy in general practice Br J Gen Pract. 49 1999 463 464
15. Gerson L.B., Robbins A.S., and Garber A. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal ref lux disease Am J Gastroenterol. 95 2000 395 407
16. Meineche-Schmidt V., Juhl H.H., and Ostergaard J.E. Costs and efficacy of three different esomeprazole treatment strategies for long-term management of gastrooesophageal reflux symptoms in primary care Aliment Pharmacol Ther. 19 2004 907 915
17. Metz D.C., Bochenek W.J. Pantoprazole US GERD Study Group Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis Aliment Pharmacol Ther. 17 2003 155 164
18. Plein K., Hotz J., and Wurzer H. Pantoprazole 20 mg is an effective maintenance therapy for patients with gastro-oesophageal reflux disease Eur J Gastroenterol Hepatol. 12 2000 425 432
19. Escourrou J., Deprez P., and Saggioro A. Maintenance therapy with pantoprazole 20 mg prevents relapse of ref lux oesophagitis Aliment Pharmacol Ther. 13 1999 1481 1491
20. Scholten T, Dekkers CP, Schütze K, et al. On-demand therapy with pantoprazole20 mg as effective long-term management of reflux disease in patients with mild GERD: The ORION trial. Digestion. In press.
21. Kaspari S, Kupcinskas L, Heinze H, et al. On-demand therapy with pantoprazole20 mg as effective long-term management of patients suffering from mild GERD. Ear J Gastroenterol Hepatol. In press.
22. [in German] Savary M., and Miller G. The Esophagus Textbook and Endoscopy Atlas 1977 Gassmann Soluthurn, Switzerland
23. Siewert J.R., Ottenjann R., and Heilmann K. Therapy and prevention of reflux esophagitis. Results of a multicenter study with cimetidine. I: Epidemiology and results of acute therapy Z Gastroenterol. 24 1986 381 395
24. ICH Topic E6 European Agency for the Evaluation of Medicinal Products Accessed July 26, 2005 International Conference on Harmonisation-World Health Organization. Guideline for Good Clinical Practice[EMEA Web site] 2002 WHO Geneva, Switzerland Accessed July 26, 2005 Accessed July 26, 2005
25. World Medical Association Declaration of Helsinki: Recommendations Guiding Medical Doctors in Biomedical Research Involving Human Subjects [WMA Website] 1989 WMA Ferney-Voltaire, France
26. Hollander M., and Wolfe D.A. Nonparametric Statistical Methods 2nd ed. 1999 Wiley and Sons New York, NY
27. Abstract Top P.A.H., van der Eijk I., and Schook C.E. Efficacy and safety of pantoprazole used continuously or intermittently in patients with mild gastro-esophageal reflux disease Gut. 52 Suppl 6 2003 A178
28. Abstract Lacevic N., Vukobrat Bijedic Z., and Gavrankapetanovic F. Efficacy of continued and 'on-demand' regimens of pantoprazole 20 mg in mild gastroesophageal reflux disease Gut. 52 Supp16 2003 A128
29. Abstract Engels L.G., Klinkenberg-Knol E.C., and Dekkers C.P.M. Esomeprazole continuous versus on-demand maintenance therapy in 1052 gastroesophageal reflux disease patients: Similar satisfaction but superior quality of life for once daily treatment Gut. 52 Supp16 2003 A130